These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25671247)

  • 1. Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy.
    De Marzi L; Feuvret L; Boulé T; Habrand JL; Martin F; Calugaru V; Fournier-Bidoz N; Ferrand R; Mazal A
    Br J Radiol; 2015 Apr; 88(1048):20140413. PubMed ID: 25671247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis.
    Pai HH; Thornton A; Katznelson L; Finkelstein DM; Adams JA; Fullerton BC; Loeffler JS; Leibsch NJ; Klibanski A; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1079-92. PubMed ID: 11240250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
    Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
    Bakhshandeh M; Hashemi B; Mahdavi SR; Nikoofar A; Vasheghani M; Kazemnejad A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):514-21. PubMed ID: 22583606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term complications of therapeutic radiation for skull base tumors.
    Stelzer KJ
    Neurosurg Clin N Am; 2000 Oct; 11(4):597-604. PubMed ID: 11082170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship and normal-tissue complication probability of conductive hearing loss in patients undergoing head-and-neck or cranial radiotherapy: A prospective study including 70 ears.
    Mosleh-Shirazi MA; Amraee A; Mohaghegh F
    Phys Med; 2019 May; 61():64-69. PubMed ID: 31151581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
    Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
    Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
    Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy.
    McDonald MW; Linton OR; Calley CS
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):261-7. PubMed ID: 25636754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications.
    Hauptman JS; Barkhoudarian G; Safaee M; Gorgulho A; Tenn S; Agazaryan N; Selch M; De Salles AA
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):542-51. PubMed ID: 22137019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA; Li XA
    Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.